⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

FULC

Fulcrum Therapeutics, Inc.

Healthcare · Biotechnology

3.84USD

+0.0200 (+0.52%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Calls on FULC

  • @VIC_BOT · Sep 3, 2026BUY

    Buy FULC at $3.65

    Imported from Value Investors Club — mack885

    +5.2%

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$-0.11▲$-0.3110
Next quarter$-0.06▲$-0.3310
Current year$-0.66▲$-1.1711
Next year$-0.49▲$-1.3310

Recent quarters

Beat in 2 of the last 4

QuarterEstimateActualSurprise
2026-06-30$-0.22$-0.22+0.00 (+1.7%)
2026-03-31$-0.3$-0.25+0.05 (+16.8%)
2025-12-31$-0.3$-0.31-0.01 (-2.3%)
2025-09-30$-0.29$-0.31-0.02 (-5.5%)

Wall Street coverage

93 ratings from 15 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
JP MorganDowngraded from OverweightUnderweight—Jun 3, 2026
StifelDowngraded from BuyHold$25 $3Jun 2, 2026
Piper SandlerDowngraded from OverweightUnderweight$23 $3Jun 2, 2026
Truist SecuritiesDowngraded from BuyHold$17 $4Jun 2, 2026
Leerink PartnersDowngraded from OutperformMarket Perform$24 $4Jun 2, 2026
HC Wainwright & Co.Downgraded from BuyNeutral$25 $3Jun 2, 2026
JP MorganInitiatedOverweight$20Jan 12, 2026
Truist SecuritiesMaintainedBuy$14 $18Dec 11, 2025
B of A SecuritiesMaintainedUnderperform$6 $7Dec 9, 2025
RBC CapitalMaintainedSector Perform$7 $10Dec 8, 2025
Cantor FitzgeraldMaintainedOverweight$15 $24Dec 8, 2025
Piper SandlerReiteratedOverweight$16 $23Dec 8, 2025
HC Wainwright & Co.MaintainedBuy$18 $25Dec 8, 2025
Truist SecuritiesInitiatedBuy$14Nov 24, 2025
HC Wainwright & Co.MaintainedBuy$12 $18Nov 24, 2025
RBC CapitalMaintainedSector Perform$5 $7Oct 30, 2025
Piper SandlerReiteratedOverweight$12.5 $16Oct 30, 2025
HC Wainwright & Co.ReiteratedBuy$12Oct 20, 2025
RBC CapitalMaintainedSector Perform$4 $5Jul 30, 2025
HC Wainwright & Co.Upgraded from NeutralBuy$4 $12Jul 29, 2025
Piper SandlerMaintainedOverweight$6 $9May 29, 2025
Leerink PartnersUpgraded from Market PerformOutperform$4 $12May 23, 2025
Cantor FitzgeraldUpgraded from NeutralOverweight$10May 15, 2025
HC Wainwright & Co.ReiteratedNeutral$4Feb 26, 2025
RBC CapitalReiteratedSector Perform$4Nov 14, 2024

Insider transactions

10 filings from 6 insiders · 2 buy / 1 sell over 6m

Officers and directors of FULC, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
TANG KEVIN CBeneficial Owner of more than 10% of a Class of SecurityBuyindirect167.6k$3.52$595kJul 17, 2026
TANG KEVIN CBeneficial Owner of more than 10% of a Class of SecurityBuyindirect249.9k$3.54$891kJul 15, 2026
EZEKOWITZ ALANDirectorSell18.0k$3.65$66kJun 26, 2026
GOULD ROBERT J.DirectorSell15.0k$10.72$161kFeb 2, 2026
GOULD ROBERT J.DirectorSell15.0k$10.87$163kJan 2, 2026
GOULD ROBERT J.DirectorSell15.0k$11.87$178kJan 2, 2026
OLTMANS CURTIS GALEOfficerSell3.5k$12.92$45kDec 15, 2025
RA CAPITAL HEALTHCARE FUND,L.P.Beneficial Owner of more than 10% of a Class of SecuritySellindirect4.18M$13.33$58.38MDec 8, 2025
GOULD ROBERT J.DirectorSell15.0k$11.03$165kNov 19, 2025
TOURANGEAU GREGOfficerSell498$5.06$3kMay 8, 2025

Analyst Notes

Sign in to write
  • @VIC_BOT wrote a note on FULC · Sep 3, 2026Buy

    FULCRUM THERAPEUTICS INC (FULC)

    0 likes · 0 comments

Analyst Ratings

4 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current00501Hold3.33
1 mo ago00502Sell3.57
2 mo ago00503Sell3.75
Price target$3.50$3.00 – $4.00
-8.9% to target